Recently, TCL Group Co., Ltd. and the original shareholder of Beijing Sinopharm Hengrui Meilian Company formally signed an equity transfer agreement. TCL invested 31.09 million yuan to acquire part of the shares of the original shareholder such as China Medical Device Industry Co., Ltd., and increased capital of 21.22 million yuan to become a new The company's largest shareholder, accounting for 51.8% of the shares. This marks the first time that TCL Group in China's consumer electronics industry has invested in medical devices and officially entered the medical electronics industry. Earlier, international consumer electronics giants GE, Philips, and Siemens have long been involved in the medical device market.
Mr. Li Dongsheng, Chairman of TCL Group, said in an interview with reporters that “the medical electronics field has a high growth rate and a high return on investment, and the medical electronics field has a certain correlation with the TCL multimedia industry. TCL can rely on its strong display technology. Entering the medical electronics industry and further expanding existing resources, the medical electronics industry will become a new business growth point for TCL. TCL's recent goal is to solidly build existing investment projects and initially form the basis for supporting future industrialization development. The goal is to establish the industrialization of medical electronics within the group and to form a leading edge in the industry."
The person in charge of the project said that after three years of turning losses into profits, TCL has a stable financial position. In addition to continuing to develop core industry multimedia and communication services, TCL has been actively seeking new profit growth points.
The consumer electronics industry and the medical device field have related synergies. For example, consumer electronics giants GE, Philips, and Siemens have already entered the medical device market and have formed a certain scale.
According to the statistics of the European Medical Device Committee, in 2008, the global medical device market total sales of about 336 billion US dollars, in recent years, the growth rate is more than 10%. China is a major medical device producer in Asia and the world, and one of the top ten emerging markets for medical devices worldwide. In recent years, China's medical device industry has developed rapidly. In 2008, the total consumption of actual medical devices was 220 billion yuan. The target value of medical devices will reach 350 billion yuan by the end of 2010. At the end of the 12th Five-Year Plan, it will reach 765 billion yuan. It reached 1.575 billion yuan. The average annual growth rate is maintained at around 18%-20%.
Dingmin Pharmaceutical supply Amiodrone API and Amiodrone Intermediates with high purity and best price. The main products CAS No are as follows: 1951-26-4, 52490-15-0. Sample can be sent if you request.
Welcome to do business with us. Please email to us directly.
4-Hydroxy-Benzoy1,Arrhythmia Intermediates,Cas 52490-15-0
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com